DSIP Dosing: What Research Shows About Delta Sleep-Inducing Peptide

DSIP dosing in research is most often described as 100 to 500 mcg per injection, given once nightly about 30 to 60 minutes before bed, while older clinical studies used weight-based amounts near 25 to 50 nmol/kg. There is no FDA-approved DSIP medicine and no single agreed-upon protocol, so reported amounts vary by route, study era, and product quality. The information below summarizes what researchers have published; it is not a personal recommendation.

What DSIP Is and Why the Dose Varies So Much

Delta sleep-inducing peptide is a short chain of nine amino acids that was first isolated from rabbit brain tissue in the 1970s. Early work focused on slow-wave sleep, and later studies looked at stress response and pain signaling.

DSIP was never developed into an approved drug, which is why a standard dose never emerged:

• Human studies were small, old, and run in different countries with different purity standards.
• Researchers used intravenous, intramuscular, subcutaneous, and intranasal routes, and absorption differs a great deal between them.
• Circulating DSIP is broken down quickly, so timing relative to sleep matters as much as the number on the label.
• Most modern material is sold as a research chemical, meaning the actual contents of a vial are not independently verified.

Because of those gaps, the idea of one "correct" DSIP dose is misleading. Researchers compare protocols, not a single gold-standard number.

DSIP Dosing Ranges by Route

The table below summarizes the amounts that appear most often in published summaries and self-reported logs. Older papers favored weight-based intravenous dosing, while modern research generally uses fixed subcutaneous amounts.

Route	Commonly described research range	Typical timing	Notes
Subcutaneous	100–500 mcg per dose	30–60 min before bed	Most common modern protocol; slow, steady absorption
Intramuscular	100–500 mcg per dose	30–60 min before bed	Slightly faster uptake; more injection-site discomfort
Intravenous	25–50 nmol/kg (about 20–40 mcg/kg)	Clinician-supervised settings	Used in older sleep studies; not practical at home
Intranasal	100–300 mcg per nostril	15–30 min before bed	Absorption is inconsistent between users

Most write-ups place the practical research range at 100 to 300 mcg per night, and dose-response data beyond that point are weak.

A DSIP dose of 100 to 300 mcg subcutaneously at bedtime is the most frequently described modern research protocol. Higher amounts are not linked to better sleep outcomes in the available literature.

How to Work Out a Dose from a 5 mg Vial

DSIP is usually sold in 5 mg vials of lyophilized powder, so a dsip 5mg dosage cannot be measured until the powder is reconstituted. A dsip dosage calculator online will run the arithmetic, but the formula itself is simple: desired dose divided by concentration equals the volume to draw.

Bacteriostatic water added	Concentration	Volume for 100 mcg	Volume for 250 mcg	Volume for 500 mcg
1 mL	5,000 mcg/mL	0.02 mL (2 units)	0.05 mL (5 units)	0.1 mL (10 units)
2 mL	2,500 mcg/mL	0.04 mL (4 units)	0.1 mL (10 units)	0.2 mL (20 units)
5 mL	1,000 mcg/mL	0.1 mL (10 units)	0.25 mL (25 units)	0.5 mL (50 units)

Units assume a U-100 insulin syringe, where 1 unit equals 0.01 mL. More diluent makes small doses easier to measure and lowers the chance of a tenfold error.

General reconstitution steps

1. Wipe the vial stopper and the diluent stopper with an alcohol swab and let both dry.
2. Draw the chosen volume of bacteriostatic water and inject it slowly down the inside wall of the vial rather than onto the powder.
3. Swirl gently; do not shake, since foaming can degrade the peptide.
4. Let the vial sit until the powder dissolves completely and the liquid is clear.
5. Label the vial with the concentration and date, then refrigerate it protected from light.

Timing and What DSIP Is Studied For

DSIP peptide for sleep is the main area of interest, and timing is treated as part of the protocol. In the original sleep research the peptide was given shortly before lights out, and modern logs follow the same pattern.

• Most protocols place the dose 30 to 60 minutes before bed.
• Some users report vivid dreams or a heavy, relaxed feeling in the first hour.
• Any effect on sleep architecture is usually described over consecutive nights rather than after a single dose.
• Because the peptide clears quickly, a morning dose is unlikely to match the timing used in sleep studies.

Sleep is complex, and a peptide is not a substitute for treating conditions such as sleep apnea or chronic insomnia with a clinician.

Reported Side Effects and Safety Considerations

Most dsip side effects described in small studies and user logs are mild, but the safety database is thin. Common complaints include headache, dizziness, nausea, injection-site irritation, and morning grogginess.

• No long-term human safety data exist for repeated nightly use.
• Purity problems in research-grade vials can cause reactions unrelated to DSIP itself.
• Peptides are not recommended during pregnancy or breastfeeding, or alongside sedatives, without medical supervision.

DSIP is not approved by the FDA for human use in the United States, and no DSIP product has an established safe dose for treating any medical condition. Anyone with a sleep disorder should talk with a healthcare professional about approved options first.

Legal Status, Sourcing, and Related Peptides

Most vendors sell DSIP labeled "for research use only." That label means the product is not intended for human consumption and is not reviewed for purity, potency, or sterility by any regulator.

Researchers who track other compounds sometimes cross-reference protocols such as aod-9604 dosing schedule female when comparing weekly versus nightly schedules, although that peptide is studied for fat metabolism rather than sleep. Stacking unrelated peptides without data raises the risk of unexpected interactions.

There is no universally accepted DSIP dosing protocol, so any schedule should be discussed with a qualified healthcare professional.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical DSIP dose for sleep?

Research summaries most often describe 100 to 300 mcg injected subcutaneously about 30 to 60 minutes before bed, while some older clinical studies used 25 to 50 nmol/kg intravenously. There is no FDA-approved dose because DSIP is not an approved drug. A healthcare professional can help you judge whether an unapproved peptide is appropriate at all.

How do I reconstitute a 5 mg DSIP vial?

Add bacteriostatic water to the vial: 1 mL gives 5,000 mcg/mL, 2 mL gives 2,500 mcg/mL, and 5 mL gives 1,000 mcg/mL. Swirl gently instead of shaking, then refrigerate the reconstituted vial and protect it from light. Using more diluent makes small doses easier to measure accurately.

Does DSIP have side effects?

Reported effects include headache, dizziness, nausea, vivid dreams, injection-site irritation, and morning grogginess. No long-term safety data exist for nightly human use, and purity varies between research suppliers. Anyone with a sleep disorder should speak with a healthcare professional about evaluated treatments.